Speach therapy for the dysarthria of Parkinson's disease;La rééducation orthophonique de la dysarthrie Parkinsonienne

Revue Neurologique

Volumn 161, Issue 8-9, 2005, Pages 857-861

  Ozsancak, C ^a   Auzou, P ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Neurologue Service d'Exploration Fonctionnelle Neurologique   (France)

Author keywords

Dysarthria; Handicap; Parkinson'disease; Quality of life; Speech therapy orthophonique

Indexed keywords

LEVODOPA;

DISABILITY; DYSARTHRIA; HUMAN; PARKINSON DISEASE; QUALITY OF LIFE; REVIEW; SPEECH THERAPY; TREATMENT OUTCOME;

EID: 25844433632     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(05)85150-1     Document Type: Review

References (30)

1. CHEVREI-MULLER C, ROUBEAU B. (2001). Rééducation et prise en charge de la dysarthrie. In: Auzou P, Ozsancak C, Brun V (eds), Les dysarthries. Masson. Paris, pp. 239-256.
2. DARLEY FL, ARONSON AE, BROWN JR. (1975). Motor speech disorders. WB Saunders. Philadelphia.
3. DEANE KHO, WHURR R, PLAYFORD ED, BENSHLOMO Y, CLARKE CE. (2003a). Speech and Language therapy versus placebo or no intervention for dysarthria in Parkinson's disease (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford.
4. DEANE KHO, WHURR R, PLAYFORD ED, BENSHLOMO Y, CLARKE CE. (2003b). Speech and Language therapy for dysarthria in Parkinson's disease: a comparison of techniques (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford.
5. DE ANGELIS EC, MOURAO LF, FERRAZ HB, BEHLAU MS, PONTES PAL, ANDRADE LAF. (1997). Effect of voice rehabilitation on oral communication of Parkinson's disease patients. Acta Neurol Scand, 96: 199-205.
6. DE SWART BJ, WILLEMSE SC, MAASSEN BA, HORSTINK MW. (2003). Improvement of voicing in patients with Parkinson's disease by speech therapy. Neurology, 60: 498-500.
7. ENDERBY P. (1983). Frenchay Dysarthria Assessment. College Hill Press, San Diego.
8. HAMMEN VL, YORKSTON KM, MINIFIE FD. (1994). Effect of temporal alteration on speech intelligibility in Parkinson dysarthria. J Speech Hear Res, 37: 244-253.
9. HANEISHI E. (2001). Effects of music therapy voice protocol on speech intelligibility, vocal acoustic measures, and mood of individuals with Parkinson's disease. J Music Ther, 38: 273-290.
10. HARTELIUS L, SVENSSON P, BUDACH A. (1993). Clinical assessment of dysarthria: Performance on a dysarthria test by normal adult subjects, and by individuals with Parkinson's disease or with multiple sclerosis. Scand J Log Phon, 18: 131-141.
11. JOHNSON JA, PRING TR. (1990). Speech therapy and Parkinson's disease: a review and further data. Br J Dis Comm, 25: 183-194.
12. LOGEMANN J, FISHER HB, BOSHES B, BLONSKY ER. (1978). Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Dis, 43: 47-57.
13. MUTCH WJ, STRUDWICK A, ROY SK, DOWNIE AW. (1986). Parkinson's disease: disability, review, and management. Br Med J, 293: 675-677.
14. OZSANCAK C, CABREJO L, JAN M, AUZOU P, HANNEQUIN D. (2003). Efficacy of an intensive speech treatment (LSVT) in Parkinson's disease: a pilot study of 22 French patients. J Neurol, 250 (suppl 2): S33.
15. PINTO S, OZSANCAK C, TRIPOLITI E, THOBOIS S, LIMOUSIN-DOWSEY P, AUZOU P. (2004). Treatment of dysarthria in Parkinson's disease: updating the thoughts. Lancet Neurology, 3: 547-556.
16. RAMIG LO, COUNTRYMAN S, THOMPSON LL, HORII Y. (1995). Comparison of two forms of intensive speech treatment for Parkinson Disease. J Speech Hear Res, 38: 1232-1251.
17. RAMIG LO. (1998). Treatment of speech and voice problems associated with Parkinson's disease. Top Geriatr Rehabil, 14: 28-43.
18. RAMIG LO, SAPIR S, COUNTRYMAN S et al. (2001a). Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. J Neurol Neurosurg Psychiatry, 71: 493-498.
19. RAMIG LO, SAPIR S, Fox C, COUNTRYMAN S. (2001b). Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord, 16: 79-83.
20. RAY J. (2002). Orofacial myofunctional therapy in dysarthria: a study on speech intelligibility. Int J Orofacial Myology, 28: 39-48.
21. ROBERTSON SJ, THOMSON F. (1984). Speech therapy in Parkinson's disease: A study of the efficacy and long term effects of intensive treatment. Br J Dis Communication, 19: 213-224.
22. ROBERTSON SJ, THOMSON F. (1999). Rééduquer les dysarthriques. L'Ortho-Edition. Isbergues (France).
23. ROBERTSON SJ. (1982). Dysarthria Profile: background and development. College of Speech Therapists Bulletin, 370: 10-12.
24. SCOTT S, CAIRD F. (1983). Speech therapy for Parkinson's disease. J Neurol Neurosurg Psychiatry, 46: 140-144.
25. SCOTT S, CAIRD F. (1984). The response of the apparent receptive speech disorder of Parkinson's disease to speech therapy. J Neurol Neurosurg Psychiatry, 47: 302-304.
26. SELLARS C, HUGHES T, LANGHORNE P. (2002). Speech and language therapy for dysarthria due to nonprogressive brain damage: a systematic Cochrane review. Clin Rehabil, 16: 61-68.
27. SHARKAWI AE, RAMIG L, LOGEMANN JA et al. (2002). Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT) a pilot study. J Neurol Neurosurg Psychiatry, 72: 31-36.
28. SPIELMAN JL, BOROD JC, RAMIG LO. (2003). The effects of intensive voice treatment on facial expressiveness in Parkinson's disease. Cogn Behav Neurol, 16: 177-188.
29. YORKSTON KM, HAMMEN VL, BEUKELMAN DR, TRAYNOR CD. (1990). The effect of rate control on the intelligibility and naturalness of dysarthric speech. J Speech Hear Res, 35: 550-560.
30. ZIEGLER M. (2000). La rééducation des troubles de la communication et de la sphère ORL. Conférence de consensus. Rev Neurol (Paris), 156 (suppl 2bis): 211-216.